COVID-19 and the Heart and Vasculature Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease

被引:24
作者
Kadosh, Bernard S. [1 ]
Garshick, Michael S. [1 ]
Gaztanaga, Juan [3 ]
Moore, Kathryn J. [1 ]
Newman, Jonathan D. [1 ]
Pillinger, Michael [2 ,4 ]
Ramasamy, Ravichandran [1 ]
Reynolds, Harmony R. [1 ]
Shah, Binita [4 ]
Hochman, Judith [1 ]
Fishman, Glenn, I [1 ]
Katz, Stuart D. [1 ]
机构
[1] NYU, Dept Med, Leon H Charney Div Cardiol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA
[2] Dept Med, Div Rheumatol, New York, NY USA
[3] NYU, Dept Cardiol, Winthrop Hosp, Div Internal Med, Mineola, NY USA
[4] VA New York Harbor Healthcare Syst, Dept Med, New York, NY USA
基金
美国国家卫生研究院;
关键词
inflammation; morbidity; mortality; pandemics; viruses; C-REACTIVE PROTEIN; ALDOSE REDUCTASE; NLRP3; INFLAMMASOME; CLINICAL CHARACTERISTICS; SGLT2; INHIBITORS; OXIDATIVE STRESS; IL-1; FAMILY; ACTIVATION; OUTCOMES; COLCHICINE;
D O I
10.1161/ATVBAHA.120.314513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The coronavirus disease 2019 (COVID-19) pandemic presents an unprecedented challenge and opportunity for translational investigators to rapidly develop safe and effective therapeutic interventions. Greater risk of severe disease in COVID-19 patients with comorbid diabetes mellitus, obesity, and heart disease may be attributable to synergistic activation of vascular inflammation pathways associated with both COVID-19 and cardiometabolic disease. This mechanistic link provides a scientific framework for translational studies of drugs developed for treatment of cardiometabolic disease as novel therapeutic interventions to mitigate inflammation and improve outcomes in patients with COVID-19.
引用
收藏
页码:2045 / 2053
页数:9
相关论文
共 113 条
[21]   Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study [J].
de Lusignan, Simon ;
Dorward, Jienchi ;
Correa, Ana ;
Jones, Nicholas ;
Akinyemi, Oluwafunmi ;
Amirthalingam, Gayatri ;
Andrews, Nick ;
Byford, Rachel ;
Dabrera, Gavin ;
Elliot, Alex ;
Ellis, Joanna ;
Ferreira, Filipa ;
Bernal, Jamie Lopez ;
Okusi, Cecilia ;
Ramsay, Mary ;
Sherlock, Julian ;
Smith, Gillian ;
Williams, John ;
Howsam, Gary ;
Zambon, Maria ;
Joy, Mark ;
Hobbs, F. D. Richard .
LANCET INFECTIOUS DISEASES, 2020, 20 (09) :1034-1042
[22]  
Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]
[23]   Overview of the IL-1 family in innate inflammation and acquired immunity [J].
Dinarello, Charles A. .
IMMUNOLOGICAL REVIEWS, 2018, 281 (01) :8-27
[24]   Interleukin-1 in the pathogenesis and treatment of inflammatory diseases [J].
Dinarello, Charles A. .
BLOOD, 2011, 117 (14) :3720-3732
[25]   A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 [J].
Donoghue, M ;
Hsieh, F ;
Baronas, E ;
Godbout, K ;
Gosselin, M ;
Stagliano, N ;
Donovan, M ;
Woolf, B ;
Robison, K ;
Jeyaseelan, R ;
Breitbart, RE ;
Acton, S .
CIRCULATION RESEARCH, 2000, 87 (05) :E1-E9
[26]   Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes [J].
Doyen, Denis ;
Moceri, Pamela ;
Ducreux, Dorothee ;
Dellamonica, Jean .
LANCET, 2020, 395 (10235) :1516-1516
[27]   NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals [J].
Duewell, Peter ;
Kono, Hajime ;
Rayner, Katey J. ;
Sirois, Cherilyn M. ;
Vladimer, Gregory ;
Bauernfeind, Franz G. ;
Abela, George S. ;
Franchi, Luigi ;
Nunez, Gabriel ;
Schnurr, Max ;
Espevik, Terje ;
Lien, Egil ;
Fitzgerald, Katherine A. ;
Rock, Kenneth L. ;
Moore, Kathryn J. ;
Wright, Samuel D. ;
Hornung, Veit ;
Latz, Eicke .
NATURE, 2010, 464 (7293) :1357-U7
[28]   Viroporins and inflammasomes: A key to understand virus-induced inflammation [J].
Farag, N. S. ;
Breitinger, U. ;
Breitinger, H. G. ;
El Azizi, M. A. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2020, 122
[29]   Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function [J].
Ferrario, CM ;
Trask, AJ ;
Jessup, JA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (06) :H2281-H2290
[30]  
Fox SE, 2020, MEDRXIV, DOI [10.1101/2020.04.06.20050575, 10.1016/s2213-2600(20)30243-5]